Tenofovir alafenamide
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Brand name
- Bocimed
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- api, pharmaceutical, tenofovir alafenamide
- Category
- Pharmaceutical Intermediates
Shanghai Bocimed Pharmaceutical Co., Ltd.
- Verified Certificate
-
7
Product name | Tenofovir alafenamide | Certification | - |
---|---|---|---|
Category | Pharmaceutical Intermediates | Ingredients | - |
Keyword | api , pharmaceutical , tenofovir alafenamide | Unit Size | - |
Brand name | Bocimed | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
We manufacture and provide Tenofovir alafenamide API with commercial capability
CAS 379270-37-8
Purity is ≥ 99%
Welcome to inquire!
Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir . It was developed by Gilead Sciences for use in the treatment of HIV infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ms. Ying
- Address
- Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
- Product Category
- Organic Intermediate
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
Shanghai Bocimed Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in drug research and development technical services, one of Shanghai high-tech enterprises, Shanghai integrity created enterprise, Shanghai SME innovation enterprises. The company started in 2007, formerly known as Shanghai MABCT Medicine Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in sales of raw materials, the drug import registration and China regional cooperation development.
Bocimed is focus on the R&D and manufacture of pharmaceutical API and intermediates, has the R&D center in Shanghai with more than 2500m2, and the factory is located in Gansu Province, China.
- Main Product
Related Products
Cas 160149-03-1
Betamethasone 17-valerate
2,3,4,4'-Tetrehydroxybenzophenone, CAS NO.: 31127-54-5
Water Soluble Chitosan
Hydrocoralliaire- Klonopin- Lexapro